NCT04037956 Tubeless NOSES Versus Laparoscopic Radical Resection for Rectosigmoid Cancers
| NCT ID | NCT04037956 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
| Condition | Tubeless NOSES |
| Study Type | INTERVENTIONAL |
| Enrollment | 458 participants |
| Start Date | 2019-06-01 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 458 participants in total. It began in 2019-06-01 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed to evaluate the short-term and long-term results after Tubeless NOSES for the resection of Rectosigmoid Cancers compared with traditional laparoscopic radical resection.
Eligibility Criteria
Inclusion Criteria: 1. Histologically or cytologically confirmed Rectosigmoid Cancers 2. Clinical stage at T 1-3 N0-2 M0 3. Tumors on peritoneal reflection，Tumor size is no more than 3 cm 4. Eastern Cooperative Oncology Group (ECOG) scale is 0-2 5. American Society of Anesthesiologists (ASA) score is Ⅰ-Ⅲ 6. BMI ≤ 30 kg/m2 7. Subjects must be willing and able to comply with scheduled visits, treatment schedule,and laboratory testing. Exclusion Criteria: 1. Heart, lung, liver or renal or any organ function that are intolerance for surgery 2. History of treated colorectal malignant disease 3. Subjects with medical condition, such as intestinal obstruction, intestinal perforation, bleeding, requires emergency surgery 4. Subjects with previous malignancies 5. History of inflammatory bowl disease(IBD) or familial adenomatous polyposis (FAP) 6. Treatment with any other clinical trial within 28 days prior to randomization 7. History of severe mentally disease 8. pregnant or lactating women 9. The researchers believe that the patients are unsuitable to participate in the researchers with other cases.
Contact & Investigator
Yanxin Luo, phD
STUDY CHAIR
The Sixth Affiliate Hospital of Sun Yat-Sen University
Frequently Asked Questions
Who can join the NCT04037956 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Tubeless NOSES. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04037956 currently recruiting?
Yes, NCT04037956 is actively recruiting participants. Contact the research team at luoyx25@mail.sysu.edu.cn for enrollment information.
Where is the NCT04037956 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT04037956 clinical trial?
NCT04037956 is sponsored by Sixth Affiliated Hospital, Sun Yat-sen University. The principal investigator is Yanxin Luo, phD at The Sixth Affiliate Hospital of Sun Yat-Sen University. The trial plans to enroll 458 participants.